Literature DB >> 8550585

Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase-deficient G alpha 16.

L E Heasley1, J Zamarripa, B Storey, B Helfrich, F M Mitchell, P A Bunn, G L Johnson.   

Abstract

Small cell lung carcinoma (SCLC) accounts for 20-25% of primary lung cancers and is rapidly growing, widely metastatic, and rarely curable. Autocrine stimulation of multiple G protein-coupled neuropeptide receptor systems contributes to the transformed growth of SCLC. The ability of neuropeptide receptors to stimulate phospholipase C and mobilize intracellular Ca2+ indicates that Gq family members of heterotrimeric G proteins are a convergence point mediating autocrine signaling by multiple neuropeptides in SCLC. Expression of a GTPase-deficient, constitutive active form of an alpha q family member, alpha 16Q212L, in SCLC markedly inhibited growth of the cells in soft agar and tumor formation in nude mice. SCLC lines expressing alpha 16Q212L exhibited 2-4-fold elevated basal phospholipase C activity, but neuropeptide and hormone-regulated intracellular Ca2+ mobilization was nearly abolished. The data suggest that Ca2+ mobilization is an obligatory signal in neuropeptide-stimulated growth of SCLC. In addition, the proline-directed c-Jun NH2-terminal kinases/stress-activated protein kinases, which are members of the mitogen-activated protein kinase family, were stimulated approximately 2-fold in parental SCLC in response to exogenous neuropeptides and muscarinic agonists and were constitutively activated to the same degree in alpha 16Q212L-expressing SCLC. Thus, alpha 16Q212L expression induced desensitizaton of neuropeptide-stimulated Ca2+ signaling and persistent activation of the c-Jun NH2-terminal kinase/stress-activated protein kinase pathway. We propose that the induction of discordant signaling by selective perturbation of receptor-regulated effector systems leads to the inhibition of SCLC cell growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550585     DOI: 10.1074/jbc.271.1.349

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Regulation of mGluR1 expression in human melanocytes and melanoma cells.

Authors:  Hwa Jin Lee; Brian A Wall; Janet Wangari-Talbot; Suzie Chen
Journal:  Biochim Biophys Acta       Date:  2012-07-05

2.  Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.

Authors:  K B Chow; Y H Wong; H Wise
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Constitutive inositol phosphate formation in cytomegalovirus-infected human fibroblasts is due to expression of the chemokine receptor homologue pUS28.

Authors:  Rosalba Minisini; Calogero Tulone; Anke Lüske; Detlef Michel; Thomas Mertens; Peter Gierschik; Barbara Moepps
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

Authors:  A Mallat; A M Préaux; C Serradeil-Le Gal; D Raufaste; C Gallois; D A Brenner; C Bradham; J Maclouf; V Iourgenko; L Fouassier; D Dhumeaux; P Mavier; S Lotersztajn
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism.

Authors:  Daniel Chan; Lajos Gera; John Stewart; Barbara Helfrich; Marileila Verella-Garcia; Gary Johnson; Anna Baron; Jie Yang; Theodore Puck; Paul Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

6.  Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.

Authors:  Sreedevi Avasarala; Rama Kamesh Bikkavilli; Michelle Van Scoyk; Wei Zhang; Ajibike Lapite; Logan Hostetter; Joshua T Byers; Lynn E Heasley; Jang Won Sohn; Robert A Winn
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.